Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Enhancing Tregs can protect against alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Immune changes and specific genes contribute to male hair loss.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Fetal skin has unique immune cells different from adult skin.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

JAK inhibitors might help treat alopecia areata.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

NXC736 significantly reduced hair loss in mice with alopecia areata.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Clonally expanded CD8+ T cells cause alopecia areata.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.